NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) ? Myeloproliferative Neoplasms Version 3.2019 — September 4, 2019 NCCN Continue Version 3.2019, 09/04/19 ? National Comprehensive Cancer Network, Inc. 2019, All rights reserved. The NCCN Guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN . ? ? Printed by Maria Chen on 9/15/2019 11:36:40 PM. For personal use only. Not approved for distribution. Copyright ? 2019 National Comprehensive Cancer Network, Inc., All Rights Reserved. NCCN Guidelines Version 3.2019 Myeloproliferative Neoplasms NCCN Guidelines Index Table of Contents Discussion *Aaron T. Gerds, MD, MS/Chair ? ? Case Comprehensive Cancer Center/ University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute Andrew T. Kuykendall, MD ? Mo?tt Cancer Center David S. Snyder, MD ? ξ City of Hope National Medical Center Brandon McMahon, MD ? University of Colorado Cancer Center Brady L. Stein, MD, MHS ? T Robert H. Lurie Comprehensive Cancer Center of Northwestern University Sanjay R. Mohan, MD ? Vanderbilt-Ingram Cancer Center *Jason Gotlib, MD, MS/Vice-Chair ? Stanford Cancer Institute Moshe Talpaz, MD ? University of Michigan Rogel Cancer Center Vivian Oehler, MD ? Fred Hutchinson Cance Research Center/ Seattle Cancer Care Alliance Prithviraj Bose, MD ? The University of Texas MD Anderson Cancer Center Swapna Thota, MD ? Roswell Park Comprehensive Cancer Center Stephen Oh, MD, PhD ? Pankit Vachhani, MD ? ONeal Comprehensive Cancer Center at UAB Michael W. Deininger, MD, PhD ? Huntsman Cancer Institute at the University of Utah Siteman Cancer Center at Barnes-Jewish Hospit